Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 10, 2022 02:00 ET | Source: MeMed

MeMed raises $93M to accelerate commercialization of its host immune-response product portfolio

MeMed raises $93M to accelerate commercialization of its host immune-response product portfolio MeMed BV® test recently cleared for use by US FDA to aid in distinguishing between bacterial and viral...
December 01, 2021 07:00 ET | Source: MeMed

Clinical data published in Clinical Microbiology and Infection support use of MeMed’s test in reducing antibiotic overuse in children

Clinical data published in Clinical Microbiology and Infection support use of MeMed’s test in reducing antibiotic overuse in children The study demonstrated the test’s high performance in...
December 01, 2021 02:00 ET | Source: MeMed

Clinical data published in Clinical Microbiology and Infection support use of MeMed’s test in reducing antibiotic overuse in children

Clinical data published in Clinical Microbiology and Infection support use of MeMed’s test in reducing antibiotic overuse in children The study demonstrated the test’s high performance in...
September 20, 2021 02:00 ET | Source: MeMed

FDA Clears First Technology to Distinguish between Bacterial and Viral Infections Using the Body’s Immune Response – The MeMed BV® Test and MeMed Key® Platform

FDA Clears First Technology to Distinguish between Bacterial and Viral Infections Using the Body’s Immune Response – The MeMed BV® Test and MeMed Key® Platform MeMed BV is a first-of-its kind test...
September 20, 2021 02:00 ET | Source: MeMed

FDA Clears First Technology to Distinguish between Bacterial and Viral Infections Using the Body’s Immune Response – The MeMed BV® Test and MeMed Key® Platform

FDA Clears First Technology to Distinguish between Bacterial and Viral Infections Using the Body’s Immune Response – The MeMed BV® Test and MeMed Key® Platform MeMed BV is a first-of-its kind test...
August 05, 2021 07:00 ET | Source: MeMed

MeMed Named a Finalist for AACC’s Disruptive Technology Award for MeMed COVID-19 Severity™ Test

MeMed Named a Finalist for AACC’s Disruptive Technology Award for MeMed COVID-19 Severity™ Test MeMed COVID-19 Severity reads the immune-system in real time to accurately determine whether...
July 27, 2021 02:00 ET | Source: MeMed

MeMeds COVID-19 Severity Test erhält die CE-Kennzeichnung für die Vorhersage von schwerwiegenden Krankheitsverläufen bei COVID-19-Patienten*innen

MeMeds COVID-19 Severity Test erhält die CE-Kennzeichnung für die Vorhersage von schwerwiegenden Krankheitsverläufen bei COVID-19-Patienten*innenDer MeMed COVID-19 Severity™ Test analysiert das...
July 27, 2021 02:00 ET | Source: MeMed

Il test di gravità del COVID-19 di MeMed ottiene il marchio CE per la previsione di esiti gravi nei pazienti affetti da COVID-19

Il test di gravità del COVID-19 di MeMed ottiene il marchio CE per la previsione di esiti gravi nei pazienti affetti da COVID-19Il test di gravità del COVID-19 di MeMed analizza il sistema immunitario...
July 27, 2021 02:00 ET | Source: MeMed

Le test MeMed COVID-19 Severity reçoit le marquage CE pour la prévision des complications sévères chez les patients atteints de COVID-19

Le test MeMed COVID-19 Severity reçoit le marquage CE pour la prévision des complications sévères chez les patients atteints de COVID-19MeMed COVID-19 Severity évalue le système immunitaire en temps...
July 27, 2021 02:00 ET | Source: MeMed

MeMed’s COVID-19 Severity Test Receives CE Mark for Predicting Severe Outcomes in COVID-19 Patients

MeMed’s COVID-19 Severity Test Receives CE Mark for Predicting Severe Outcomes in COVID-19 PatientsMeMed COVID-19 Severity reads the immune-system in real time to accurately determine whether...

keyboard_arrow_left Previous Page

Next Page keyboard_arrow_right